Fungal infections in humans: the silent crisis
- PMID: 32548176
- PMCID: PMC7278517
- DOI: 10.15698/mic2020.06.718
Fungal infections in humans: the silent crisis
Abstract
Annually, over 150 million severe cases of fungal infections occur worldwide, resulting in approximately 1.7 million deaths per year. Alarmingly, these numbers are continuously on the rise with a number of social and medical developments during the past decades that have abetted the spread of fungal infections. Additionally, the long-term therapeutic application and prophylactic use of antifungal drugs in high-risk patients have promoted the emergence of (multi)drug-resistant fungi, including the extremely virulent strain Candida auris. Hence, fungal infections are already a global threat that is becoming increasingly severe. In this article, we underline the importance of more and effective research to counteract fungal infections and their consequences.
Keywords: Candida; antifungals; antimycotics; azoles; drug; resistance; yeast.
Copyright: © 2020 Kainz et al.
Conflict of interest statement
Conflict of interest: D.C-G. and F.M. are the scientific co-founders of Samsara Therapeutics, a company that develops novel pharmacological autophagy inducers. F.M. and D.C-G. have equity interests in TLL (The Longevity Labs), a company that develops natural food extracts.
References
-
- WHO. The top 10 causes of death. 2018 Available at https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. [Accessed 15.05.2020]
-
- WHO. Global Tuberculosis Report. 2019 Available at https://www.who.int/tb/publications/global_report/en/. [Accessed 15.05.2020]
-
- WHO. World Malaria Report. 2019 Available at https://www.who.int/publications-detail/world-malaria-report-2019. [Accessed 15.05.2020]
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous